Individualization of neoadjuvant therapy for breast cancer according to molecular tumor characteristics

Nat Clin Pract Oncol. 2005 Dec;2(12):598-9. doi: 10.1038/ncponc0375.
No abstract available

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / therapeutic use*
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / genetics*
  • Female
  • Humans
  • Neoadjuvant Therapy*
  • Receptor, ErbB-2 / genetics
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Antineoplastic Agents, Hormonal
  • Receptor, ErbB-2
  • Trastuzumab